Venus Concept Inc. (VERO)
USD 2.47
(3.35%)
USD 2.47
(3.35%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 107.1 Million USD | -8.18% |
| 2022 | 116.64 Million USD | 3.89% |
| 2021 | 112.27 Million USD | -3.85% |
| 2020 | 116.76 Million USD | 2.02% |
| 2019 | 114.44 Million USD | 289.4% |
| 2018 | 29.39 Million USD | 48.62% |
| 2017 | 19.77 Million USD | -87.87% |
| 2016 | 163.04 Million USD | 9.66% |
| 2015 | 148.68 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 75.38 Million USD | -29.54% |
| 2024 Q1 | 106.98 Million USD | -0.11% |
| 2023 Q3 | 110.29 Million USD | -1.25% |
| 2023 Q2 | 111.69 Million USD | -1.17% |
| 2023 Q1 | 113.01 Million USD | -3.11% |
| 2023 Q4 | 107.1 Million USD | -2.9% |
| 2023 FY | 107.1 Million USD | -8.18% |
| 2022 Q4 | 116.64 Million USD | 5.45% |
| 2022 Q1 | 110.99 Million USD | -1.14% |
| 2022 FY | 116.64 Million USD | 3.89% |
| 2022 Q2 | 109.35 Million USD | -1.48% |
| 2022 Q3 | 110.61 Million USD | 1.15% |
| 2021 Q1 | 112.8 Million USD | -3.39% |
| 2021 Q4 | 112.27 Million USD | 2.64% |
| 2021 Q3 | 109.38 Million USD | -0.95% |
| 2021 FY | 112.27 Million USD | -3.85% |
| 2021 Q2 | 110.42 Million USD | -2.11% |
| 2020 FY | 116.76 Million USD | 2.02% |
| 2020 Q4 | 116.76 Million USD | 5.8% |
| 2020 Q3 | 110.36 Million USD | -0.2% |
| 2020 Q2 | 110.58 Million USD | 1.75% |
| 2020 Q1 | 108.68 Million USD | -5.04% |
| 2019 Q2 | 36.15 Million USD | 2.44% |
| 2019 Q1 | 35.29 Million USD | 20.09% |
| 2019 Q3 | 42.54 Million USD | 17.68% |
| 2019 FY | 114.44 Million USD | 289.4% |
| 2019 Q4 | 114.44 Million USD | 168.98% |
| 2018 FY | 29.39 Million USD | 48.62% |
| 2018 Q1 | 19.79 Million USD | 0.08% |
| 2018 Q3 | 28.42 Million USD | -0.05% |
| 2018 Q2 | 28.43 Million USD | 43.68% |
| 2018 Q4 | 29.39 Million USD | 3.4% |
| 2017 Q2 | 24.83 Million USD | 0.0% |
| 2017 Q4 | 19.77 Million USD | -88.76% |
| 2017 Q3 | 176.01 Million USD | 608.66% |
| 2017 FY | 19.77 Million USD | -87.87% |
| 2016 FY | 163.04 Million USD | 9.66% |
| 2016 Q4 | 163.04 Million USD | 0.0% |
| 2015 FY | 148.68 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -108.965% |
| BrainsWay Ltd. | 15.31 Million USD | -599.38% |
| Cerus Corporation | 144.3 Million USD | 25.78% |
| Envoy Medical, Inc. | 9.4 Million USD | -1039.151% |
| electroCore, Inc. | 8.94 Million USD | -1097.35% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -1904.923% |
| IceCure Medical Ltd | 4.24 Million USD | -2421.851% |
| Inogen, Inc. | 121.38 Million USD | 11.764% |
| OrthoPediatrics Corp. | 72.56 Million USD | -47.604% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -262.067% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -3265.962% |
| MaxCyte, Inc. | 36.1 Million USD | -196.627% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -5695.899% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -25084.055% |
| Orthofix Medical Inc. | 326.58 Million USD | 67.205% |
| PAVmed Inc | 57.13 Million USD | -87.449% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -320.622% |
| RxSight, Inc. | 22.18 Million USD | -382.707% |
| Sight Sciences, Inc. | 46.43 Million USD | -130.646% |
| SI-BONE, Inc. | 61.05 Million USD | -75.435% |
| TELA Bio, Inc. | 59.16 Million USD | -81.018% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 6.024% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -937.92% |
| Acutus Medical, Inc. | 54.83 Million USD | -95.304% |
| Talis Biomedical Corporation | 29.22 Million USD | -266.49% |
| Spectral AI, Inc. | 12.4 Million USD | -763.664% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -362.968% |
| CVRx, Inc. | 39.28 Million USD | -172.652% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -795.654% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -4308.801% |
| Bioventus Inc. | 589.79 Million USD | 81.841% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -107.311% |
| LivaNova PLC | 1.15 Billion USD | 90.702% |
| 908 Devices Inc. | 37.49 Million USD | -185.684% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 84.775% |
| Nemaura Medical Inc. | 26.37 Million USD | -306.04% |
| NeuroPace, Inc. | 86.99 Million USD | -23.111% |
| LENSAR, Inc. | 22.4 Million USD | -377.946% |
| Apyx Medical Corporation | 52.31 Million USD | -104.715% |
| Cutera, Inc. | 518.12 Million USD | 79.329% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -265.19% |
| BioSig Technologies, Inc. | 4.68 Million USD | -2186.083% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -83.499% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -398.432% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 95.119% |
| Axonics, Inc. | 82.35 Million USD | -30.044% |
| Outset Medical, Inc. | 190.91 Million USD | 43.9% |
| IRIDEX Corporation | 24.91 Million USD | -329.891% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 13.602% |
| IRadimed Corporation | 20.73 Million USD | -416.509% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -6298.029% |
| INVO Bioscience, Inc. | 19.99 Million USD | -435.65% |
| Telesis Bio, Inc. | 40.87 Million USD | -162.039% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -162.57% |
| Varex Imaging Corporation | 668.6 Million USD | 83.981% |
| Quipt Home Medical Corp. | 136.29 Million USD | 21.417% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -2898.404% |
| Pulmonx Corporation | 60.63 Million USD | -76.633% |
| Dynatronics Corporation | 11.78 Million USD | -809.185% |
| Modular Medical, Inc. | 2.27 Million USD | -4614.04% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -2535.408% |
| Semler Scientific, Inc. | 6.27 Million USD | -1608.182% |
| InMode Ltd. | 75.91 Million USD | -41.085% |
| Bruker Corporation | 2.83 Billion USD | 96.224% |
| Cytosorbents Corporation | 29.98 Million USD | -257.183% |
| DexCom, Inc. | 4.19 Billion USD | 97.447% |
| Align Technology, Inc. | 2.45 Billion USD | 95.634% |
| Viveve Medical, Inc. | 10.84 Million USD | -887.397% |
| ZimVie Inc. | 795.85 Million USD | 86.542% |
| Movano Inc. | 5.97 Million USD | -1693.419% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -2.388% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -25084.055% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -795.654% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 83.24% |
| Profound Medical Corp. | 12.66 Million USD | -745.604% |
| Insulet Corporation | 1.85 Billion USD | 94.228% |
| enVVeno Medical Corporation | 2.43 Million USD | -4298.48% |
| Surmodics, Inc. | 65.82 Million USD | -62.714% |
| iCAD, Inc. | 8 Million USD | -1238.62% |
| Nuwellis, Inc. | 6.78 Million USD | -1479.69% |
| Biotricity, Inc. | 35.91 Million USD | -198.176% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 51.982% |
| Aethlon Medical, Inc. | 2.47 Million USD | -4219.279% |
| InspireMD, Inc. | 8.14 Million USD | -1215.439% |
| PAVmed Inc. | 57.13 Million USD | -87.449% |
| BIOLASE, Inc. | 35.34 Million USD | -202.996% |
| Beyond Air, Inc. | 29.77 Million USD | -259.708% |
| FONAR Corporation | 57.45 Million USD | -86.404% |
| AxoGen, Inc. | 101.16 Million USD | -5.873% |
| Vivani Medical, Inc. | 25.03 Million USD | -327.796% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -21.991% |
| Inari Medical, Inc. | 209.32 Million USD | 48.834% |
| UFP Technologies, Inc. | 118.04 Million USD | 9.269% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -743.962% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -4799.918% |
| Tenon Medical, Inc. | 5.56 Million USD | -1823.891% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -5920.405% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -507.362% |
| AdaptHealth Corp. | 3.15 Billion USD | 96.603% |
| Sintx Technologies, Inc. | 6.59 Million USD | -1524.496% |
| NanoVibronix, Inc. | 2.68 Million USD | -3887.453% |
| Quanterix Corporation | 78.08 Million USD | -37.164% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -2898.404% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -2092.487% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 89.748% |
| TransMedics Group, Inc. | 568.84 Million USD | 81.172% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -542.027% |
| NeuroMetrix, Inc. | 1.33 Million USD | -7933.986% |
| Hyperfine, Inc. | 9.8 Million USD | -992.888% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 57.201% |
| Biomerica, Inc. | 2.66 Million USD | -3921.893% |
| Bone Biologics Corporation | 831.4 Thousand USD | -12782.216% |
| AVITA Medical, Inc. | 19.86 Million USD | -439.143% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -5326.555% |
| Silk Road Medical, Inc | 114.15 Million USD | 6.18% |